Orozco Tomas 4
4 · NeueHealth, Inc. · Filed May 6, 2024
Insider Transaction Report
Form 4
NeueHealth, Inc.NEUE
Orozco Tomas
EVP, Consumer Care
Transactions
- Award
Restricted Stock Units
2024-05-02+72,000→ 72,000 total→ Common Stock (72,000 underlying) - Award
Restricted Stock Units
2024-05-02+180,000→ 180,000 total→ Common Stock (180,000 underlying)
Footnotes (5)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]This grant was approved on March 11, 2024 by the Issuer's Compensation and Human Capital Committee as part of the Issuer's annual equity grants, subject to shareholder approval of an amendment to the Issuer's Amended and Restated 2021 Omnibus Incentive Plan, which approval was obtained on May 2, 2024.
- [F3]These restricted stock units vest in three equal annual installments beginning on March 11, 2025.
- [F4]This grant was approved on October 11, 2023 by the Issuer's Compensation and Human Capital Committee, subject to shareholder approval of an amendment to the Issuer's Amended and Restated 2021 Omnibus Incentive Plan, which approval was obtained on May 2, 2024.
- [F5]100% of these restricted stock units vest on October 11, 2026.